ClinConnect ClinConnect Logo
Search / Trial NCT05026814

Clitoral Reconstruction (CR) in FGM/C Patients

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 24, 2021

Trial Information

Current as of May 10, 2025

Completed

Keywords

Clitoral Reconstruction (Cr) Psychosexual Care (Pc)

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Signed informed consent of the present study
  • French and / or English speaking
  • Exclusion Criteria:
  • Insufficient knowledge of project language (French/English)
  • No informed consent
  • Inability to sign consent

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Genève, , Switzerland

Patients applied

0 patients applied

Trial Officials

Jasmine Abdulcadir, PD Dr. med.

Principal Investigator

Department of Obstetrics and Gynecology, University Hospital of Geneva (HUG)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials